/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

E

Erica S. Klaassen

Centre for Human Drug Research(NL)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

73

Papers

957

Citations

19

h-index

33

i10-index

Erica S. Klaassen is an academic researcher from Centre for Human Drug Research. The author has contributed to research in topics: Neuroscience and Neuropharmacology Research & Receptor Mechanisms and Signaling & Cholinesterase and Neurodegenerative Diseases. The author has an h-index of 19, co-authored 63 publications.

ORCID: 0000-0003-0089-1846

Research Topics

Neuroscience and Neuropharmacology Research Receptor Mechanisms and Signaling Cholinesterase and Neurodegenerative Diseases Epilepsy research and treatment Pain Mechanisms and Treatments

Papers by this author

works

Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer's disease

2019 · NeuroImage · 50 citations

https://doi.org/10.1016/j.neuroimage.2019.05.044

Bernadet L. Klaassens Joop van Gerven Erica S. Klaassen Jeroen van der Grond

Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI

2020 · Alzheimer s Research & Therapy · 23 citations

https://doi.org/10.1186/s13195-019-0567-z

Jolien F. Leijenaar Geert Jan Groeneveld Erica S. Klaassen Anna E. Leeuwis

Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers

2022 · Translational Psychiatry · 19 citations

https://doi.org/10.1038/s41398-022-02148-w

Francis M. Dijkstra Patricio O’Donnell Erica S. Klaassen Derek L. Buhl

Safety, Pharmacokinetics, and Pharmacodynamics of a First‐in‐Class <scp>ClC</scp>‐1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial

2024 · Clinical Pharmacology & Therapeutics · 3 citations

https://doi.org/10.1002/cpt.3516

Titia Q. Ruijs Catherine M.K.E. de Cuba Jules A. A. C. Heuberger John B. Hutchison

Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses — a randomized, placebo-controlled clinical trial

2024 · Immunologic Research · 2 citations

https://doi.org/10.1007/s12026-024-09484-7

Boukje C. Eveleens Maarse Micha N. Ronner Manon A. A. Jansen Tessa Niemeyer‐van der Kolk

<scp>TMS</scp> and <scp>EEG</scp> Pharmacodynamic Effects of a Selective Sphingosine‐1‐Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects

2024 · Clinical Pharmacology & Therapeutics · 2 citations

https://doi.org/10.1002/cpt.3521

Catherine M.K.E. de Cuba Annika A. de Goede Erica S. Klaassen Marije E. Otto

Research topics

topics

Neuroscience and Neuropharmacology Research

Receptor Mechanisms and Signaling

Cholinesterase and Neurodegenerative Diseases

Epilepsy research and treatment

Pain Mechanisms and Treatments

Chat about Author

Papers

Chat

Click to start Chat